The Pipeline Center

Filter Your Results




The Next Frontier of Disease Monitoring and Management?

Judy E. Kim, MD

November/December 2018—How home-based telemedicine could be transformational for patients with AMD.

Are You Ready for the Future of Vitreoretinal Surgery?

S.K. Steven Houston III, MD; and John B. Miller, MD

November/December 2018—It’s anyone’s guess what tomorrow’s ORs will look like. Here, these authors build from their imaginations.

Getting Ahead With AI Automation

Megan A. Kasetty, BS; Jay C. Wang, MD; and John B. Miller, MD

November/December 2018—Recent advances in this technology may help streamline screening and examinations and allow retina specialists to diagnose disease in patients remotely.

Retina News

October 2018—Apellis Begins PHASE 3 Trials FOR COMPLEMENT INHIBITION in GA Two phase 3 trials of a complement-inhibiting peptide have begun, assessing the safety and efficacy of the com…

Retina News

September 2018—Aflibercept Label Now Includes 12-Week Dosing Interval for AMD The US FDA in August approved an updated label for aflibercept (Eylea, Regeneron), adding every-12-week injec…

Retina News

July/August 2018—NOVARTIS PLANS TO SPIN OFF ALCON Novartis plans to spin off its eye care devices division, Alcon, into a separately traded standalone company, the company announced in June…

Topical Drug Delivery for Retinal Disease Management

David S. Boyer, MD

July/August 2018—The cornea and sclera stand in the way of this more convenient, less invasive drug delivery modality.

Less Invasive Treatment for Uveitis

Glenn J. Jaffe, MD

July/August 2018—An injectable sustained drug delivery system may have advantages over existing options.


This Month's Supplements


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.